Leishmanicidal and cytotoxic activities and 4D‐QSAR of 2‐arylidene indan‐1,3‐diones

The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2‐arylidene indan‐1,3‐diones is described. The compounds were evaluated against the leukemia cell lines...

Full description

Saved in:
Bibliographic Details
Published inArchiv der Pharmazie (Weinheim) Vol. 354; no. 10; pp. e2100081 - n/a
Main Authors Souza, Ana P. M., Costa, Maria C. A., Aguiar, Alex R., Bressan, Gustavo C., Almeida Lima, Graziela D., Lima, Wallace P., Borsodi, Maria P. G., Bergmann, Bartira R., Ferreira, Márcia M. C., Teixeira, Róbson R.
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2‐arylidene indan‐1,3‐diones is described. The compounds were evaluated against the leukemia cell lines HL60 and Nalm6, and the most effective ones were 2‐(4‐nitrobenzylidene)‐1H‐indene‐1,3(2H)‐dione (4) and 4‐[(1,3‐dioxo‐1H‐inden‐2(3H)‐ylidene)methyl]benzonitrile (10), presenting IC50 values of around 30 µmol/L against Nalm6. The leishmanicidal activity was assessed on Leishmania amazonensis, with derivative 4 (IC50 = 16.6 µmol/L) being the most active. A four‐dimensional quantitative structure–activity analysis (4D‐QSAR) was applied to the indandione derivatives, through partial least‐squares regression. The statistics presented by the regression models built with the selected field descriptors of Coulomb (C) and Lennard‐Jones (L) nature, considering the activities against L. amazonensis, HL60, and Nalm6 leukemia cells, were, respectively, R2 = 0.88, 0.92, and 0.98; Q2 = 0.83, 0.88, and 0.97. The presence of positive Coulomb descriptors near the carbonyl groups indicates that these polar groups are related to the activities. Besides, the presence of positive Lennard‐Jones descriptors close to substituents R3 or R1 indicates that bulky nonpolar substituents in these positions tend to increase the activities. This study provides useful insights into the mode of action of indandione derivatives for each biological activity involved. The evaluation of 16 indan‐1,3‐dione derivatives against HL60 and Nalm6 cells revealed that, in general, the compounds were more effective against Nalm6 cells. The compounds were also assessed, for the first time, on Leishmania amazonensis. Four‐dimensional quantitative structure–activity models were developed for the evaluated activities. Useful insights into the mode of action of the indandione derivatives, for each biological activity involved, are described.
AbstractList The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2‐arylidene indan‐1,3‐diones is described. The compounds were evaluated against the leukemia cell lines HL60 and Nalm6, and the most effective ones were 2‐(4‐nitrobenzylidene)‐1H‐indene‐1,3(2H)‐dione (4) and 4‐[(1,3‐dioxo‐1H‐inden‐2(3H)‐ylidene)methyl]benzonitrile (10), presenting IC50 values of around 30 µmol/L against Nalm6. The leishmanicidal activity was assessed on Leishmania amazonensis, with derivative 4 (IC50 = 16.6 µmol/L) being the most active. A four‐dimensional quantitative structure–activity analysis (4D‐QSAR) was applied to the indandione derivatives, through partial least‐squares regression. The statistics presented by the regression models built with the selected field descriptors of Coulomb (C) and Lennard‐Jones (L) nature, considering the activities against L. amazonensis, HL60, and Nalm6 leukemia cells, were, respectively, R2 = 0.88, 0.92, and 0.98; Q2 = 0.83, 0.88, and 0.97. The presence of positive Coulomb descriptors near the carbonyl groups indicates that these polar groups are related to the activities. Besides, the presence of positive Lennard‐Jones descriptors close to substituents R3 or R1 indicates that bulky nonpolar substituents in these positions tend to increase the activities. This study provides useful insights into the mode of action of indandione derivatives for each biological activity involved.
Abstract The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2‐arylidene indan‐1,3‐diones is described. The compounds were evaluated against the leukemia cell lines HL60 and Nalm6, and the most effective ones were 2‐(4‐nitrobenzylidene)‐1 H ‐indene‐1,3(2 H )‐dione ( 4 ) and 4‐[(1,3‐dioxo‐1 H ‐inden‐2(3 H )‐ylidene)methyl]benzonitrile ( 10 ), presenting IC 50 values of around 30 µmol/L against Nalm6. The leishmanicidal activity was assessed on Leishmania amazonensis , with derivative 4 (IC 50 = 16.6 µmol/L) being the most active. A four‐dimensional quantitative structure–activity analysis (4D‐QSAR) was applied to the indandione derivatives, through partial least‐squares regression. The statistics presented by the regression models built with the selected field descriptors of Coulomb (C) and Lennard‐Jones (L) nature, considering the activities against L. amazonensis , HL60, and Nalm6 leukemia cells, were, respectively, R 2 = 0.88, 0.92, and 0.98; Q 2 = 0.83, 0.88, and 0.97. The presence of positive Coulomb descriptors near the carbonyl groups indicates that these polar groups are related to the activities. Besides, the presence of positive Lennard‐Jones descriptors close to substituents R 3 or R 1 indicates that bulky nonpolar substituents in these positions tend to increase the activities. This study provides useful insights into the mode of action of indandione derivatives for each biological activity involved.
The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2‐arylidene indan‐1,3‐diones is described. The compounds were evaluated against the leukemia cell lines HL60 and Nalm6, and the most effective ones were 2‐(4‐nitrobenzylidene)‐1H‐indene‐1,3(2H)‐dione (4) and 4‐[(1,3‐dioxo‐1H‐inden‐2(3H)‐ylidene)methyl]benzonitrile (10), presenting IC50 values of around 30 µmol/L against Nalm6. The leishmanicidal activity was assessed on Leishmania amazonensis, with derivative 4 (IC50 = 16.6 µmol/L) being the most active. A four‐dimensional quantitative structure–activity analysis (4D‐QSAR) was applied to the indandione derivatives, through partial least‐squares regression. The statistics presented by the regression models built with the selected field descriptors of Coulomb (C) and Lennard‐Jones (L) nature, considering the activities against L. amazonensis, HL60, and Nalm6 leukemia cells, were, respectively, R2 = 0.88, 0.92, and 0.98; Q2 = 0.83, 0.88, and 0.97. The presence of positive Coulomb descriptors near the carbonyl groups indicates that these polar groups are related to the activities. Besides, the presence of positive Lennard‐Jones descriptors close to substituents R3 or R1 indicates that bulky nonpolar substituents in these positions tend to increase the activities. This study provides useful insights into the mode of action of indandione derivatives for each biological activity involved. The evaluation of 16 indan‐1,3‐dione derivatives against HL60 and Nalm6 cells revealed that, in general, the compounds were more effective against Nalm6 cells. The compounds were also assessed, for the first time, on Leishmania amazonensis. Four‐dimensional quantitative structure–activity models were developed for the evaluated activities. Useful insights into the mode of action of the indandione derivatives, for each biological activity involved, are described.
The indan-1,3-dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the leishmanicidal and cytotoxicity evaluation of 16 2-arylidene indan-1,3-diones is described. The compounds were evaluated against the leukemia cell lines HL60 and Nalm6, and the most effective ones were 2-(4-nitrobenzylidene)-1H-indene-1,3(2H)-dione (4) and 4-[(1,3-dioxo-1H-inden-2(3H)-ylidene)methyl]benzonitrile (10), presenting IC values of around 30 µmol/L against Nalm6. The leishmanicidal activity was assessed on Leishmania amazonensis, with derivative 4 (IC = 16.6 µmol/L) being the most active. A four-dimensional quantitative structure-activity analysis (4D-QSAR) was applied to the indandione derivatives, through partial least-squares regression. The statistics presented by the regression models built with the selected field descriptors of Coulomb (C) and Lennard-Jones (L) nature, considering the activities against L. amazonensis, HL60, and Nalm6 leukemia cells, were, respectively, R = 0.88, 0.92, and 0.98; Q = 0.83, 0.88, and 0.97. The presence of positive Coulomb descriptors near the carbonyl groups indicates that these polar groups are related to the activities. Besides, the presence of positive Lennard-Jones descriptors close to substituents R or R indicates that bulky nonpolar substituents in these positions tend to increase the activities. This study provides useful insights into the mode of action of indandione derivatives for each biological activity involved.
Author Almeida Lima, Graziela D.
Lima, Wallace P.
Ferreira, Márcia M. C.
Aguiar, Alex R.
Bergmann, Bartira R.
Borsodi, Maria P. G.
Costa, Maria C. A.
Teixeira, Róbson R.
Souza, Ana P. M.
Bressan, Gustavo C.
Author_xml – sequence: 1
  givenname: Ana P. M.
  surname: Souza
  fullname: Souza, Ana P. M.
  organization: Universidade Federal de Viçosa
– sequence: 2
  givenname: Maria C. A.
  surname: Costa
  fullname: Costa, Maria C. A.
  organization: University of Campinas
– sequence: 3
  givenname: Alex R.
  surname: Aguiar
  fullname: Aguiar, Alex R.
  organization: Universidade Federal de Viçosa
– sequence: 4
  givenname: Gustavo C.
  surname: Bressan
  fullname: Bressan, Gustavo C.
  organization: Universidade do Grande Rio
– sequence: 5
  givenname: Graziela D.
  surname: Almeida Lima
  fullname: Almeida Lima, Graziela D.
  organization: Universidade Federal de Viçosa
– sequence: 6
  givenname: Wallace P.
  surname: Lima
  fullname: Lima, Wallace P.
  organization: Universidade Federal do Rio de Janeiro
– sequence: 7
  givenname: Maria P. G.
  surname: Borsodi
  fullname: Borsodi, Maria P. G.
  organization: Universidade Federal do Rio de Janeiro
– sequence: 8
  givenname: Bartira R.
  surname: Bergmann
  fullname: Bergmann, Bartira R.
  organization: Universidade Federal do Rio de Janeiro
– sequence: 9
  givenname: Márcia M. C.
  surname: Ferreira
  fullname: Ferreira, Márcia M. C.
  organization: University of Campinas
– sequence: 10
  givenname: Róbson R.
  orcidid: 0000-0003-3181-1108
  surname: Teixeira
  fullname: Teixeira, Róbson R.
  email: robsonr.teixeira@ufv.br
  organization: Universidade Federal de Viçosa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34323311$$D View this record in MEDLINE/PubMed
BookMark eNqFkLtOAzEQRS0EIuHRUqKVaChI8Pix8ZYRbykS74pi5bUd4WjjDesNkI5P4Bv5EgYSgkRD4_HMHF9d3w2yGqrgCNkB2gVK2aGu7aTLKMOGKlghbZAMOgKUWCVtylPZSRnnLbIR4wgRTplcJy0uOE4B2uRh4Hx8HOvgjbe6THSwiZk1VVO9epNo0_hn33gXvxfi-OPt_fq2f5NUw4ThXdez0lsXXOKD1QEncMDxtB5dxi2yNtRldNuLuknuT0_ujs47g8uzi6P-oGN4j6NZRVPDWCZ4QVUhqbDCsoJZyV2aKip7RcEtBcdVBkwBDEWRgRHQw9ZmLOWbZH-uO6mrp6mLTT720biy1MFV05gzKVOuUDhDdO8POqqmdUB3SPUUSMUYRao7p0xdxVi7YT6p_Rg_mwPNv2LPv2LPl7Hjg92F7LQYO7vEf3JGIJsDL750s3_k8v7N8dWv-CejupCR
CitedBy_id crossref_primary_10_3390_v13112123
crossref_primary_10_1016_j_rechem_2023_101073
crossref_primary_10_4155_fmc_2023_0246
Cites_doi 10.1016/j.ejmech.2019.111688
10.1093/qjmed/hct116
10.1016/j.ejmech.2018.02.037
10.1016/0022-1759(83)90303-4
10.3390/molecules24234411
10.2174/1389557518666180330101809
10.3390/molecules22050765
10.5306/wjco.v7.i1.54
10.29161/PT.v6.i2.2018.22
10.1002/cber.188702001137
10.1002/cem.1192
10.1016/S1359-6446(97)01079-9
10.7164/antibiotics.34.1402
10.1016/S0140-6736(18)31204-2
10.1002/minf.201000181
10.1039/C4OB02103G
10.3390/molecules25214890
10.1002/cem.1331
10.4061/2011/571242
10.1016/j.ejmech.2014.06.006
10.1590/S0100-40422013000400013
10.1016/j.drup.2004.07.002
10.1039/b508541a
10.2165/00139709-200524040-00005
10.1002/anie.201911530
10.1289/ehp.5758
10.7164/antibiotics.34.1389
10.1016/0223-5234(87)90054-7
10.1021/ci900014f
10.2174/1570179412666150817222851
10.1371/journal.pone.0035671
10.1016/j.biopha.2017.03.072
10.1080/14756360600958057
10.15171/apb.2017.041
10.3390/12051101
10.1016/j.taap.2018.08.012
10.1007/s11030-015-9589-z
10.1097/CAD.0000000000000944
10.1002/cem.3131
10.1016/j.ejmech.2017.03.078
10.3390/molecules18021881
10.3390/molecules201219857
10.7164/antibiotics.40.786
10.3390/molecules14072317
10.1016/j.pt.2003.09.008
10.1128/CMR.19.1.111-126.2006
10.1016/j.ejmech.2018.01.046
10.1016/j.tiv.2020.104777
10.1016/j.bmcl.2016.04.065
10.1007/s008940100045
10.1016/j.jcrpr.2017.07.001
10.1016/j.bmc.2016.06.027
10.1371/journal.pone.0134882
10.1016/j.tiv.2018.07.015
10.1016/j.dyepig.2017.07.009
10.3390/pathogens8040201
10.1590/S0103-50532002000600004
ContentType Journal Article
Copyright 2021 Deutsche Pharmazeutische Gesellschaft
2021 Deutsche Pharmazeutische Gesellschaft.
Copyright_xml – notice: 2021 Deutsche Pharmazeutische Gesellschaft
– notice: 2021 Deutsche Pharmazeutische Gesellschaft.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1002/ardp.202100081
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-4184
EndPage n/a
ExternalDocumentID 10_1002_ardp_202100081
34323311
ARDP202100081
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABOCM
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
GWYGA
H.T
H.X
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBFHL
WBKPD
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWP
WXSBR
WYISQ
XG1
XV2
Y6R
YCJ
ZCG
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c3731-4806c22943b08b504d4d2b2d53e668057bb3d01e38912811f4b91c417912d9263
IEDL.DBID DR2
ISSN 0365-6233
IngestDate Sat Aug 17 00:45:18 EDT 2024
Thu Oct 10 15:41:08 EDT 2024
Fri Aug 23 01:30:29 EDT 2024
Sat Sep 28 08:22:35 EDT 2024
Sat Aug 24 00:59:57 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords 2-arylidene indan-1,3-diones
cytotoxic activity
leishmanicidal activity
indan-1,3-dione
4D-QSAR
Language English
License 2021 Deutsche Pharmazeutische Gesellschaft.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3731-4806c22943b08b504d4d2b2d53e668057bb3d01e38912811f4b91c417912d9263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3181-1108
PMID 34323311
PQID 2578158220
PQPubID 866361
PageCount 16
ParticipantIDs proquest_miscellaneous_2556385049
proquest_journals_2578158220
crossref_primary_10_1002_ardp_202100081
pubmed_primary_34323311
wiley_primary_10_1002_ardp_202100081_ARDP202100081
PublicationCentury 2000
PublicationDate October 2021
2021-Oct
2021-10-00
20211001
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: October 2021
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Frankfurt
PublicationTitle Archiv der Pharmazie (Weinheim)
PublicationTitleAlternate Arch Pharm (Weinheim)
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1887; 20
2017; 7
2017; 4
2004; 7
2002; 13
2020; 59
2018; 41
1997; 2
2003; 19
2003; 111
2009; 49
2005; 24
2013; 18
2018; 6
2009; 14
2021; 32
1987; 40
2010; 24
2000
2013; 12
2019; 24
1983; 65
2014; 13
2007; 22
1981; 34
2019; 8
2009; 23
2015; 14
2015; 5
2011
2018; 149
2019; 30
2015; 94
2017; 22
2018; 146
2015; 10
2007
2006; 19
2020; 34
2017; 134
2007; 12
2019; 183
2016; 13
2012; 31
2014; 107
2011; 2011
2018; 18
1987; 22
2016; 7
2017; 90
2013; 36
2018; 392
2020; 31
2019; 42
2001; 7
2018; 356
2016; 20
2005; 7
2020; 25
2016
2015
2020; 65
2012; 7
2009; 1
2017; 147
2018; 53
2016; 26
2016; 24
e_1_2_7_5_1
Cambridge Crystallographic Data Centre (e_1_2_7_63_1) 2007
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_60_1
e_1_2_7_17_1
Dias M. C. F. (e_1_2_7_36_1) 2021; 32
e_1_2_7_62_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_64_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_45_1
e_1_2_7_68_1
e_1_2_7_47_1
Lima A. M. A. (e_1_2_7_35_1) 2019; 42
e_1_2_7_49_1
e_1_2_7_28_1
Teixeira R. R. (e_1_2_7_34_1) 2019; 30
Monzote L. (e_1_2_7_11_1) 2009; 1
Gazolla P. A. R. (e_1_2_7_37_1) 2018; 41
Wellington K. W. (e_1_2_7_61_1) 2015; 5
e_1_2_7_50_1
e_1_2_7_71_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_52_1
e_1_2_7_33_1
e_1_2_7_54_1
e_1_2_7_21_1
e_1_2_7_56_1
Guidance Document on the Validation of (Quantitative) Structure‐Activity Relationship [(Q)SAR] Models (e_1_2_7_55_1) 2007
e_1_2_7_58_1
e_1_2_7_39_1
e_1_2_7_6_1
Jeyachandran M. (e_1_2_7_26_1) 2011
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
WHO (e_1_2_7_4_1) 2015
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_65_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_67_1
e_1_2_7_48_1
e_1_2_7_69_1
Amidi S. (e_1_2_7_23_1) 2013; 12
e_1_2_7_27_1
e_1_2_7_29_1
Nielsen A. B. (e_1_2_7_66_1) 2000
e_1_2_7_72_1
e_1_2_7_51_1
e_1_2_7_70_1
e_1_2_7_30_1
e_1_2_7_53_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_22_1
e_1_2_7_57_1
e_1_2_7_20_1
e_1_2_7_59_1
e_1_2_7_38_1
References_xml – volume: 19
  start-page: 502
  year: 2003
  publication-title: Trends Parasitol.
– volume: 5
  year: 2015
  publication-title: Chem. Soc. Rev.
– volume: 4
  start-page: 127
  year: 2017
  publication-title: J. Cancer Res. Pract.
– volume: 24
  start-page: 4411
  year: 2019
  publication-title: Molecules
– volume: 7
  start-page: 306
  year: 2001
  publication-title: J. Mol. Mod.
– volume: 7
  start-page: 3297
  year: 2005
  publication-title: Phys. Chem. Chem. Phys.
– volume: 7
  year: 2012
  publication-title: PLoS One
– volume: 34
  start-page: 1402
  year: 1981
  publication-title: J. Antibiot.
– volume: 90
  start-page: 375
  year: 2017
  publication-title: Biomed. Pharmacother.
– volume: 12
  start-page: 91
  year: 2013
  publication-title: Iran. J. Pharm. Sci.
– volume: 7
  start-page: 339
  year: 2017
  publication-title: Adv. Pharm. Bull.
– volume: 7
  start-page: 257
  year: 2004
  publication-title: Drug Resist. Updates
– volume: 24
  start-page: 681
  year: 2010
  publication-title: J. Chemom.
– volume: 32
  start-page: 572
  year: 2021
  publication-title: J. Braz. Chem. Soc.
– volume: 20
  start-page: 589
  year: 1887
  publication-title: Ber. Dtsch. Chem. Ges.
– volume: 53
  start-page: 1
  year: 2018
  publication-title: Toxicol. In Vitro
– volume: 19
  start-page: 111
  year: 2006
  publication-title: Clin. Microbiol. Rev.
– volume: 22
  start-page: 765
  year: 2017
  publication-title: Molecules
– volume: 183
  year: 2019
  publication-title: Eur. J. Med. Chem.
– volume: 14
  year: 2015
  publication-title: Molecules
– volume: 23
  start-page: 32
  year: 2009
  publication-title: J. Chemom.
– volume: 13
  start-page: 601
  year: 2014
  publication-title: Org. Biomol. Chem.
– volume: 59
  start-page: 221
  year: 2020
  publication-title: Angew. Chem. Int. Ed.
– volume: 94
  start-page: 509
  year: 2015
  publication-title: Eur. J. Med. Chem.
– volume: 40
  start-page: 786
  year: 1987
  publication-title: J. Antibiot.
– volume: 14
  start-page: 2317
  year: 2009
  publication-title: Molecules
– volume: 42
  start-page: 473
  year: 2019
  publication-title: Quim. Nova
– volume: 65
  start-page: 55
  year: 1983
  publication-title: J. Immunol. Methods
– volume: 22
  start-page: 229
  year: 1987
  publication-title: Eur. J. Med. Chem.
– volume: 30
  start-page: 541
  year: 2019
  publication-title: J. Braz. Chem. Soc.
– year: 2015
– volume: 25
  start-page: 4890
  year: 2020
  publication-title: Molecules
– volume: 8
  start-page: 201
  year: 2019
  publication-title: Pathogens
– volume: 147
  start-page: 50
  year: 2017
  publication-title: Dyes Pigm.
– volume: 392
  start-page: 951
  year: 2018
  publication-title: Lancet
– volume: 49
  start-page: 1428
  year: 2009
  publication-title: J. Chem. Inf. Model.
– volume: 134
  start-page: 97
  year: 2017
  publication-title: Eur. J. Med. Chem.
– volume: 13
  start-page: 742
  year: 2002
  publication-title: J. Braz. Chem. Soc.
– volume: 24
  start-page: 259
  year: 2005
  publication-title: Toxicol. Rev.
– year: 2007
– volume: 13
  start-page: 385
  year: 2016
  publication-title: Curr. Org. Synth.
– volume: 111
  start-page: 1361
  year: 2003
  publication-title: Environ. Health Persp.
– volume: 18
  start-page: 1321
  year: 2018
  publication-title: Mini‐Rev. Org. Chem.
– volume: 41
  start-page: 497
  year: 2018
  publication-title: Quim. Nova
– year: 2000
– volume: 20
  start-page: 111
  year: 2016
  publication-title: Mol. Divers.
– volume: 12
  start-page: 1101
  year: 2007
  publication-title: Molecules
– volume: 34
  year: 2020
  publication-title: J. Chemom.
– volume: 2
  start-page: 457
  year: 1997
  publication-title: Drug Discov. Today
– volume: 107
  start-page: 7
  year: 2014
  publication-title: QJM
– volume: 2011
  year: 2011
  publication-title: Mol. Biol. Int.
– volume: 22
  start-page: 37
  year: 2007
  publication-title: J. Enzyme Inhib. Med. Chem.
– year: 2016
– volume: 1
  start-page: 9
  year: 2009
  publication-title: Open Antimicrob. Agents J.
– volume: 65
  year: 2020
  publication-title: Toxicol. In Vitro
– volume: 31
  start-page: 718
  year: 2020
  publication-title: Anticancer Drugs
– volume: 10
  year: 2015
  publication-title: PLoS One
– volume: 18
  start-page: 1881
  year: 2013
  publication-title: Molecules
– volume: 146
  start-page: 274
  year: 2018
  publication-title: Eur. J. Med. Chem.
– volume: 356
  start-page: 214
  year: 2018
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 31
  start-page: 75
  year: 2012
  publication-title: Mol. Inf.
– volume: 6
  start-page: 22
  year: 2018
  publication-title: PharmaTutor
– volume: 149
  start-page: 98
  year: 2018
  publication-title: Eur. J. Med. Chem.
– volume: 34
  start-page: 1389
  year: 1981
  publication-title: J. Antibiot.
– volume: 24
  start-page: 3829
  year: 2016
  publication-title: Bioorg. Med. Chem.
– year: 2011
  publication-title: Org. Chem. Int.
– volume: 7
  start-page: 54
  year: 2016
  publication-title: World J. Clin. Oncol.
– volume: 26
  start-page: 2810
  year: 2016
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 36
  start-page: 554
  year: 2013
  publication-title: Quim. Nova
– ident: e_1_2_7_45_1
  doi: 10.1016/j.ejmech.2019.111688
– ident: e_1_2_7_7_1
  doi: 10.1093/qjmed/hct116
– ident: e_1_2_7_31_1
  doi: 10.1016/j.ejmech.2018.02.037
– ident: e_1_2_7_62_1
  doi: 10.1016/0022-1759(83)90303-4
– ident: e_1_2_7_50_1
  doi: 10.3390/molecules24234411
– ident: e_1_2_7_20_1
  doi: 10.2174/1389557518666180330101809
– ident: e_1_2_7_28_1
  doi: 10.3390/molecules22050765
– volume: 32
  start-page: 572
  year: 2021
  ident: e_1_2_7_36_1
  publication-title: J. Braz. Chem. Soc.
  contributor:
    fullname: Dias M. C. F.
– year: 2011
  ident: e_1_2_7_26_1
  publication-title: Org. Chem. Int.
  contributor:
    fullname: Jeyachandran M.
– ident: e_1_2_7_13_1
  doi: 10.5306/wjco.v7.i1.54
– ident: e_1_2_7_59_1
  doi: 10.29161/PT.v6.i2.2018.22
– ident: e_1_2_7_15_1
  doi: 10.1002/cber.188702001137
– ident: e_1_2_7_72_1
  doi: 10.1002/cem.1192
– ident: e_1_2_7_69_1
  doi: 10.1016/S1359-6446(97)01079-9
– ident: e_1_2_7_30_1
  doi: 10.7164/antibiotics.34.1402
– ident: e_1_2_7_2_1
  doi: 10.1016/S0140-6736(18)31204-2
– ident: e_1_2_7_70_1
  doi: 10.1002/minf.201000181
– ident: e_1_2_7_49_1
  doi: 10.1039/C4OB02103G
– ident: e_1_2_7_53_1
  doi: 10.3390/molecules25214890
– volume: 42
  start-page: 473
  year: 2019
  ident: e_1_2_7_35_1
  publication-title: Quim. Nova
  contributor:
    fullname: Lima A. M. A.
– ident: e_1_2_7_57_1
  doi: 10.1002/cem.1331
– volume: 5
  year: 2015
  ident: e_1_2_7_61_1
  publication-title: Chem. Soc. Rev.
  contributor:
    fullname: Wellington K. W.
– ident: e_1_2_7_5_1
  doi: 10.4061/2011/571242
– ident: e_1_2_7_21_1
  doi: 10.1016/j.ejmech.2014.06.006
– volume-title: GaussView 3.0 User's Reference
  year: 2000
  ident: e_1_2_7_66_1
  contributor:
    fullname: Nielsen A. B.
– ident: e_1_2_7_71_1
  doi: 10.1590/S0100-40422013000400013
– ident: e_1_2_7_10_1
  doi: 10.1016/j.drup.2004.07.002
– ident: e_1_2_7_64_1
  doi: 10.1039/b508541a
– ident: e_1_2_7_65_1
– ident: e_1_2_7_22_1
  doi: 10.2165/00139709-200524040-00005
– ident: e_1_2_7_17_1
  doi: 10.1002/anie.201911530
– ident: e_1_2_7_56_1
  doi: 10.1289/ehp.5758
– ident: e_1_2_7_29_1
  doi: 10.7164/antibiotics.34.1389
– ident: e_1_2_7_24_1
  doi: 10.1016/0223-5234(87)90054-7
– ident: e_1_2_7_67_1
  doi: 10.1021/ci900014f
– ident: e_1_2_7_18_1
  doi: 10.2174/1570179412666150817222851
– ident: e_1_2_7_3_1
  doi: 10.1371/journal.pone.0035671
– ident: e_1_2_7_52_1
  doi: 10.1016/j.biopha.2017.03.072
– ident: e_1_2_7_48_1
  doi: 10.1080/14756360600958057
– volume-title:  OECD Environment Health and Safety Publications Series on Testing and Assessment No. 69
  year: 2007
  ident: e_1_2_7_55_1
  contributor:
    fullname: Guidance Document on the Validation of (Quantitative) Structure‐Activity Relationship [(Q)SAR] Models
– ident: e_1_2_7_14_1
  doi: 10.15171/apb.2017.041
– volume-title: Leishmaniasis Fact Sheet No. 375
  year: 2015
  ident: e_1_2_7_4_1
  contributor:
    fullname: WHO
– ident: e_1_2_7_44_1
  doi: 10.3390/12051101
– ident: e_1_2_7_39_1
  doi: 10.1016/j.taap.2018.08.012
– ident: e_1_2_7_19_1
  doi: 10.1007/s11030-015-9589-z
– volume: 30
  start-page: 541
  year: 2019
  ident: e_1_2_7_34_1
  publication-title: J. Braz. Chem. Soc.
  contributor:
    fullname: Teixeira R. R.
– volume-title: Cambridge Structural Database Software Version 5.29‐2007 + 1 Update
  year: 2007
  ident: e_1_2_7_63_1
  contributor:
    fullname: Cambridge Crystallographic Data Centre
– ident: e_1_2_7_33_1
  doi: 10.1097/CAD.0000000000000944
– ident: e_1_2_7_60_1
  doi: 10.1002/cem.3131
– ident: e_1_2_7_40_1
  doi: 10.1016/j.ejmech.2017.03.078
– ident: e_1_2_7_43_1
  doi: 10.3390/molecules18021881
– ident: e_1_2_7_47_1
  doi: 10.3390/molecules201219857
– ident: e_1_2_7_27_1
  doi: 10.7164/antibiotics.40.786
– ident: e_1_2_7_6_1
  doi: 10.3390/molecules14072317
– volume: 41
  start-page: 497
  year: 2018
  ident: e_1_2_7_37_1
  publication-title: Quim. Nova
  contributor:
    fullname: Gazolla P. A. R.
– ident: e_1_2_7_9_1
  doi: 10.1016/j.pt.2003.09.008
– ident: e_1_2_7_58_1
  doi: 10.3390/molecules24234411
– volume: 12
  start-page: 91
  year: 2013
  ident: e_1_2_7_23_1
  publication-title: Iran. J. Pharm. Sci.
  contributor:
    fullname: Amidi S.
– ident: e_1_2_7_8_1
  doi: 10.1128/CMR.19.1.111-126.2006
– ident: e_1_2_7_46_1
  doi: 10.1016/j.ejmech.2018.01.046
– ident: e_1_2_7_32_1
  doi: 10.1016/j.tiv.2020.104777
– ident: e_1_2_7_41_1
  doi: 10.1016/j.bmcl.2016.04.065
– ident: e_1_2_7_68_1
  doi: 10.1007/s008940100045
– ident: e_1_2_7_12_1
  doi: 10.1016/j.jcrpr.2017.07.001
– ident: e_1_2_7_25_1
  doi: 10.1016/j.bmc.2016.06.027
– ident: e_1_2_7_42_1
  doi: 10.1371/journal.pone.0134882
– volume: 1
  start-page: 9
  year: 2009
  ident: e_1_2_7_11_1
  publication-title: Open Antimicrob. Agents J.
  contributor:
    fullname: Monzote L.
– ident: e_1_2_7_38_1
  doi: 10.1016/j.tiv.2018.07.015
– ident: e_1_2_7_16_1
  doi: 10.1016/j.dyepig.2017.07.009
– ident: e_1_2_7_51_1
  doi: 10.3390/pathogens8040201
– ident: e_1_2_7_54_1
  doi: 10.1590/S0103-50532002000600004
SSID ssj0003025
Score 2.3453095
Snippet The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the...
The indan-1,3-dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the...
Abstract The indan‐1,3‐dione and its derivatives are important building blocks in organic synthesis and present important biological activities. Herein, the...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e2100081
SubjectTerms 2‐arylidene indan‐1,3‐diones
4D‐QSAR
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antiprotozoal Agents - chemical synthesis
Antiprotozoal Agents - chemistry
Antiprotozoal Agents - pharmacology
Cell Line, Tumor
cytotoxic activity
HL-60 Cells
Humans
Indans - chemical synthesis
Indans - chemistry
Indans - pharmacology
indan‐1,3‐dione
Inhibitory Concentration 50
Leishmania mexicana - drug effects
leishmanicidal activity
Leukemia
Leukemia - drug therapy
Quantitative Structure-Activity Relationship
Title Leishmanicidal and cytotoxic activities and 4D‐QSAR of 2‐arylidene indan‐1,3‐diones
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fardp.202100081
https://www.ncbi.nlm.nih.gov/pubmed/34323311
https://www.proquest.com/docview/2578158220
https://search.proquest.com/docview/2556385049
Volume 354
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9tAEF6hnHqhUGhJoWiRUHrJY1927GNEQAhBlQaQkDhY3kfUqJWDsINIT_0J_Y38Embs2G7ooRK9WGuvvd7d2Z2Z3Z35hpBD4dnA90PTYSaABYoUvBNrYIbo1GljDxGk0FH44ot_eq3ObrybP7z4C3yIasMNZ0bOr3GCxzrt1aCh0IGINyl4LtaACXPZR5uu4bjGj5Isj7rK0JQL5LwsURuZ6K1-viqV_lI1VzXXXPScvCVxWenC4uR7d57prvn5As_xf1q1QdaXeikdFANpk6y55B1pjQpg60WbXtV-WmmbtuiohrxebJHbczdNvyGUhplaKCZOLDWLbJbNHqeGou_EQ47cmmeo4dOv318vB2M6m1ABaajtD4xt6ihuECTwhLclXC2iKKXb5Prk-OrotLMM29Axsi-B4AHzjRChkpoF2mPKKiu0sJ50vh-Afqi1tIw7PCEVAecTpUNuMBIaFzYUvnxPGgmUv0OoUJoJE1pYd02UDGzgVAwKXl9Z7XxmJk3yuSRbdFegc0QFDrOIsCejqiebZK-karScpWmE7Ip7oCKxJjmosmF-4aFJnLjZHN_xgEVBK8Im-VCMhupX6JQrJYfCRU7Tf9QhGoyHo-ru42s-2iVvMF1YE-6RRnY_d59AK8r0fj7ynwF5LgOR
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6VcoBLy7OkLWWRULkk7b7s2seItAqQViGkEhIHy_uIiFo5VeNUDSd-Ar-RX8KMHTtKOSDBxbJ37fW-5rG7M98AvJGBi8Iwti1uI1ygKClaqUFmSE6dLg0IQYochU_Pwu65_vAlqKwJyRemxIeoN9yIMgp-TQROG9KHS9RQ7EECnJSikGv34D7SvKLoDZ3BEkFK8SLuKidjLpT0qsJt5PJw9ftVufSHsrmquxbC52QTTFXt0ubk4mCWmwP7_Q6i43-16xFsLFRT1i7n0mNY89kT2O-X2NbzJhsuXbWmTbbP-kvU6_lT-Nrz4-k3QtOwY4fFpJljdp5P8snt2DJyn7gpwFuLDN359ePnp8_tAZuMmMR7rO4lhTf1jPYIMkwRTYVXR0BK02dwfnI8fNdtLSI3tKw6UjjmEQ-tlLFWhkcm4NppJ410gfJhGKGKaIxyXHg6JJWRECNtYmEpGJqQLpaheg7rGZb_ApjUhksbO1x6jbSKXOR1ijrekXbGh9yOGvC2GrfkqgToSEooZplQTyZ1TzZgtxrWZEGo04Q4lghQS-INeF1nI4nRuUma-cmM3gmQS2Er4gZsldOh_hX55SolsHBZDOpf6pC0B51-_bT9Lx-9ggfd4Wkv6b0_-7gDDym9NC7chfX8euZfopKUm72CDH4DqC0HqQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB5BkRAX3pTQAouEyiVp9-WtfYwaogKlCqGVKnGwvA-LiMqpGqdqeuIn8Bv5JZ2xE4fAAQkulr1rr3d3dna_fcw3AK9l5GNjEtfhLsYJipKik1nsDMmo02cRMUiRofDHQ7N_rN-fRCe_WPHX_BDNghtpRtVfk4Kf-XxnSRqKFUh8k1JUw9pNuKUNwl-CRcMlgZTildtVTme5cKBXC9pGLndWv18dlv7AmqvQtRp7-vcgW-S6PnLybXta2m139Ruh4_8U6z7cnQNT1q1b0gO4EYqHsDWoma1nbXa0NNSatNkWGyw5r2eP4MtBGE2-EpeGG3lMJis8c7NyXI4vR46R8cRFRd1aRejez-8_Pn3uDtk4ZxLvMben5Nw0MFohKDBEtBVePdEoTR7Dcf_t0d5-Z-63oePUrkKJx9w4KROtLI9txLXXXlrpIxWMiREgWqs8F4G2SGUsRK5tIhy5QhPSJ9KoJ7BWYPpPgUltuXSJx4lXrlXs46AzRHi72ttguMtb8GYhtvSspudIayJmmVJNpk1NtmBzIdV0rqaTlPorESFG4i141USjgtGuSVaE8ZTeibCPwlIkLVivW0PzK7LKVUpg4rKS6V_ykHaHvUHz9OxfPnoJtwe9fnrw7vDDBtyh4Ppk4SaslefT8BwRUmlfVEpwDYcZBlg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leishmanicidal+and+cytotoxic+activities+and+4D-QSAR+of+2-arylidene+indan-1%2C3-diones&rft.jtitle=Archiv+der+Pharmazie+%28Weinheim%29&rft.au=de+Souza%2C+Ana+P+M&rft.au=Costa%2C+Maria+C+A&rft.au=de+Aguiar%2C+Alex+R&rft.au=Bressan%2C+Gustavo+C&rft.date=2021-10-01&rft.eissn=1521-4184&rft.volume=354&rft.issue=10&rft.spage=e2100081&rft_id=info:doi/10.1002%2Fardp.202100081&rft_id=info%3Apmid%2F34323311&rft.externalDocID=34323311
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0365-6233&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0365-6233&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0365-6233&client=summon